No definition available.
Anaphylactic shock due to adverse effect of correct drug or medication properly administered
ANAPH_SHOCK_ADVER_EFFECT_CORRE_DRUG_MEDICAM_PROPE_ADMINISTE
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
423 |
4. Check minimum number of eventsNone |
423 |
5. Include endpointsNone |
423 |
6. Filter based on genotype QC (FinnGen only) |
423 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Anaphylactic shock due to adverse effect of correct drug or medication properly administered
based on the number of shared cases.
Similar with more cases:
- Other complications of surgical and medical care, not elsewhere classified
- Complications of surgical and medical care, not elsewhere classified
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2507 | 1626 | 859 |
| Only index persons | 2350 | 1557 | 793 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.02 |
| Only index persons | 0.05 | 0.06 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 51.79 | 51.85 | 51.61 |
| Only index persons | 51.56 | 51.44 | 51.80 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 423 | 298 | 125 |
| Unadjusted period prevalence (%) | 0.09 | 0.10 | 0.06 |
| Median age at first event (years) | 53.02 | 50.66 | 58.64 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 382
- Matched controls
- 3819
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
+∞
323.0
382
*
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
98.3
173.7
185
36
C01CA24
ATC
epinephrine; parenteral
20.6
89.3
140
104
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
86.5
74.8
82
12
XQ800
NOMESCO Finland
Prick test
10.3
57.4
124
170
T78.4
ICD-10 Finland
Allergy, unspecified
15.1
50.5
87
73
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
7.8
45.9
118
207
H02AB06
ATC
prednisolone; systemic
4.7
43.5
268
1270
N02AX02
ATC
tramadol; systemic, rectal
3.2
25.1
209
1054
J01FF01
ATC
clindamycin; systemic
3.2
22.5
159
702
J45.9
ICD-10 Finland
Asthma, unspecified
3.7
21.5
110
378
Y59
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances
30.9
19.9
26
9
R03DC03
ATC
montelukast; oral
3.6
19.6
103
357
R03AC02
ATC
salbutamol; inhalant
2.7
19.5
248
1541
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.9
19.5
88
270
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
19.1
194
1048
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
18.3
19.0
29
17
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
7.6
18.1
43
63
R06AE07
ATC
cetirizine; oral
2.6
17.8
215
1267
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.2
17.6
111
439
L50.0
ICD-10 Finland
Allergic urticaria
10.0
17.6
35
38
J46
ICD-10 Finland
Status asthmaticus
10.6
17.5
34
35
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.2
16.4
67
186
R06.0
ICD-10 Finland
Dyspnoea
2.9
16.1
122
537
WX892
NOMESCO Finland
Monitored bed care
5.2
15.9
51
110
X57
ICD-10 Finland
Unspecified privation
12.5
15.8
28
24
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.5
15.6
80
269
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
11.1
15.5
29
28
R50.9
ICD-10 Finland
Fever, unspecified
3.5
15.4
80
272
N03AX12
ATC
gabapentin; oral
3.2
15.3
92
348
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.9
15.1
66
194
X58
ICD-10 Finland
Exposure to other specified factors
3.2
14.5
85
315
A02BC02
ATC
pantoprazole; systemic
2.4
14.2
261
1815
XQ801
NOMESCO Finland
Intracutantest
31.4
14.0
18
6
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.6
13.9
120
567
J01MA02
ATC
ciprofloxacin; systemic
2.4
13.8
166
935
A04AA01
ATC
ondansetron; systemic, rectal
4.2
13.3
52
138
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.9
13.2
92
381
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
17.5
13.1
20
12
J01MA12
ATC
levofloxacin; systemic
2.9
13.1
90
366
N03AX16
ATC
pregabalin; oral
2.6
13.1
113
530
J01FA06
ATC
roxithromycin; oral
2.3
13.0
179
1067
R51.80
ICD-10 Finland
Headache
3.0
12.9
84
333
N02AA05
ATC
oxycodone; systemic
3.2
12.5
71
256
C03CA01
ATC
furosemide; systemic
2.6
12.5
110
521
A92
ICPC
Allergy/allergic reaction NOS
7.9
12.4
28
38
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
12.4
100
448
N02BE01
ATC
paracetamol; systemic, rectal
3.0
12.2
342
2830
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
11.8
128
672
R55
ICD-10 Finland
Syncope and collapse
3.6
11.8
55
170
R03BA05
ATC
fluticasone; inhalant
2.6
11.8
97
440
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
11.8
166
987
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
11.7
120
612
J01AA02
ATC
doxycycline; systemic
2.4
11.6
309
2434
Y88.0
ICD-10 Finland
Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use
123.6
11.5
12
*
R06AX27
ATC
desloratadine; oral
2.3
11.5
136
741
G43.9
ICD-10 Finland
Migraine, unspecified
4.1
11.5
45
120
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
11.4
81
335
L50.9
ICD-10 Finland
Urticaria, unspecified
5.7
11.3
32
60
J01DB01
ATC
cefalexin; oral
2.6
11.3
328
2676
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
4.0
11.3
45
122
R02
ICPC
Shortness of breath/dyspnoea
3.1
11.0
62
222
UJF32
NOMESCO Finland
Coloscopy
2.4
10.9
111
558
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.8
10.7
45
128
X59
ICD-10 Finland
Exposure to unspecified factor
2.5
10.6
93
435
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.1
10.5
195
1283
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.9
10.3
43
121
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.9
10.3
43
121
ZXD05
NOMESCO Finland
Urgent procedure
2.2
10.3
143
830
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.6
10.2
85
385
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.3
10.2
37
92
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.2
10.2
54
185
H02AB07
ATC
prednisone; oral
2.7
10.1
72
298
R42
ICD-10 Finland
Dizziness and giddiness
2.4
10.1
94
452
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
10.0
64
247
J45.1
ICD-10 Finland
Nonallergic asthma
3.7
9.9
43
126
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.3
9.8
105
541
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
9.8
100
501
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
9.7
58
213
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
9.7
64
254
XF600
NOMESCO Finland
Bloodpressure measurement
4.1
9.6
37
97
XQ820
NOMESCO Finland
Exposure to medicinal substance
22.4
9.4
13
6
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
9.9
9.4
18
19
Z3231
NOMESCO Finland
Registered nurse
2.2
9.3
119
662
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.8
9.3
63
251
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
5.6
9.2
26
49
H02AB04
ATC
methylprednisolone; systemic
2.7
9.2
69
292
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.0
9.2
190
1279
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
4.1
9.1
35
92
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
2.2
9.1
100
520
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
9.0
81
381
R03DA04
ATC
theophylline; systemic, rectal
5.1
8.9
27
56
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
8.9
50
178
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
8.6
89
445
R11
ICD-10 Finland
Nausea and vomiting
3.2
8.6
46
159
R06AE09
ATC
levocetirizine; oral
2.4
8.2
71
326
S06.0
ICD-10 Finland
Concussion
2.9
8.2
51
195
J45
ICD-10 Finland
Asthma
2.8
8.1
53
207
JAH01
NOMESCO Finland
Laparoscopy
3.7
8.0
34
98
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.4
8.0
68
311
J01FA10
ATC
azithromycin; systemic
1.9
8.0
242
1834
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
6.3
8.0
20
33
R03BA02
ATC
budesonide; inhalant
2.3
8.0
81
404
R01AD09
ATC
mometasone; nasal
1.9
7.9
186
1291
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
4.7
7.9
26
59
E0000UV
ATC
NA
1.9
7.9
158
1034
N06AX21
ATC
duloxetine; oral
2.6
7.9
59
250
A03FA01
ATC
metoclopramide; systemic, rectal
2.2
7.9
94
502
ZXE00
NOMESCO Finland
One hour or less
1.9
7.8
160
1057
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.6
7.8
26
60
L17
ICPC
Foot/toe symptom/complaint
2.1
7.8
101
561
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
15.4
7.8
12
8
R03BB04
ATC
tiotropium bromide; inhalant
3.0
7.7
45
165
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
7.7
48
183
R05FB02
ATC
cough suppressants and expectorants
1.9
7.6
149
966
AA1AD
NOMESCO Finland
CT of head and brain
2.1
7.6
94
512
R53
ICD-10 Finland
Malaise and fatigue
2.2
7.6
88
464
ZX120
NOMESCO Finland
Intravenous
2.8
7.5
48
186
L50.8
ICD-10 Finland
Other urticaria
6.2
7.5
19
32
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
7.3
39
135
J01DA01
ATC
[U] cefalexin; systemic
1.8
7.3
244
1883
I50.9
ICD-10 Finland
Heart failure, unspecified
2.8
7.2
45
171
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.2
7.2
36
119
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
7.2
80
414
P01AB01
ATC
metronidazole; oral, rectal
1.8
7.1
164
1118
N05CF01
ATC
zopiclone; oral
1.9
7.1
123
757
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
3.9
7.1
28
76
J01MA14
ATC
moxifloxacin; systemic
2.9
7.1
42
156
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
7.0
163
1109
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.9
7.0
118
720
J45.8
ICD-10 Finland
Mixed asthma
5.4
7.0
20
39
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
7.0
66
314
D07AC01
ATC
betamethasone; topical
1.9
7.0
132
841
T78.3
ICD-10 Finland
Angioneurotic oedema
7.8
7.0
15
20
M79.6
ICD-10 Finland
Pain in limb
1.9
7.0
140
908
M54.8
ICD-10 Finland
Other dorsalgia
4.0
6.9
26
68
M54.4
ICD-10 Finland
Lumbago with sciatica
2.2
6.9
72
363
R01AD08
ATC
fluticasone; nasal
1.9
6.8
115
702
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.3
6.8
65
314
XQ899
NOMESCO Finland
Other assessment of skin
17.1
6.8
10
6
J33.8
ICD-10 Finland
Other polyp of sinus
7.4
6.8
15
21
M25.5
ICD-10 Finland
Pain in joint
1.9
6.7
123
770
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
6.7
43
168
L03
ICPC
Low back symptom/complaint
2.0
6.7
101
590
SPAT1312
SPAT
General health counselling
1.8
6.6
131
844
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
6.6
143
947
J01FA09
ATC
clarithromycin; systemic
1.8
6.6
137
895
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
6.6
72
370
M01AG02
ATC
tolfenamic acid; oral, rectal
2.1
6.5
76
402
J32.4
ICD-10 Finland
Chronic pansinusitis
7.6
6.5
14
19
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.8
6.5
41
158
N05BA04
ATC
oxazepam; oral
1.9
6.5
103
616
T78.0
ICD-10 Finland
Anaphylactic shock due to adverse food reaction
71.0
6.4
7
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.7
6.4
42
166
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.7
6.4
20
44
J01DC02
ATC
cefuroxime; systemic
3.2
6.4
32
107
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.1
6.3
23
59
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.5
6.3
49
212
W84
ICD-10 Finland
Unspecified threat to breathing
27.2
6.3
8
*
R01AD12
ATC
fluticasone furoate; nasal
1.8
6.1
124
802
R03BB01
ATC
ipratropium bromide; inhalant
4.7
6.1
19
42
M54.5
ICD-10 Finland
Low back pain
1.8
6.0
133
883
J01FA15
ATC
telithromycin; oral
2.4
6.0
49
219
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
6.0
116
736
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
183
805
3.24
30.17
6.2
4.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
282
1760
2.81
22.17
7.6
5.8
umol/l
8.7
10.5
5.97
270
1665
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
123
502
3.04
22.05
2.3
1.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
307
2033
2.86
20.95
14.4
8.9
e9/l
4.3
4.1
0.72
283
1773
(3019198) Lymphocytes [#/volume] in Blood
279
1791
2.64
19.72
8.3
5.6
e9/l
2.1
2.0
0.21
260
1586
(3001604) Monocytes [#/volume] in Blood
272
1738
2.58
19.20
8.4
5.6
e9/l
0.6
0.6
0.63
248
1506
(3024561) Albumin [Mass/volume] in Serum or Plasma
229
1356
2.50
18.97
6.7
4.2
g/l
35.0
36.2
2.17
214
1274
(42870588) Differential panel, method unspecified - Blood
201
1124
2.50
18.82
9.0
5.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
271
1743
2.54
18.63
8.5
5.6
e9/l
0.0
0.0
0.76
247
1514
(3013115) Eosinophils [#/volume] in Blood
277
1810
2.54
18.24
9.3
6.0
e9/l
0.2
0.2
1.50
257
1597
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
92
352
3.06
18.16
2.3
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
91
349
3.05
17.87
2.3
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
93
366
2.98
17.41
2.1
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
87
335
3.01
16.90
7.6
6.9
mmol/l
1.3
1.3
0.08
67
270
(3019069) Monocytes/100 leukocytes in Blood
252
1631
2.35
16.15
9.6
6.0
%
8.1
8.4
0.69
244
1533
(3022096) Basophils/100 leukocytes in Blood
245
1568
2.34
16.10
9.2
5.8
%
0.6
0.7
0.35
233
1460
(3032080) INR in Blood by Coagulation assay
205
1223
2.31
15.83
9.6
7.0
inr
1.1
1.2
1.03
73
386
(3006504) Eosinophils/100 leukocytes in Blood
250
1624
2.32
15.72
9.2
5.7
%
2.9
2.7
0.64
239
1514
(3002030) Lymphocytes/100 leukocytes in Blood
256
1680
2.33
15.71
9.3
5.8
%
27.6
28.7
0.72
248
1574
(3018010) Neutrophils/100 leukocytes in Blood
254
1665
2.32
15.58
8.9
5.6
%
57.9
57.0
0.59
246
1565
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
185
1063
2.32
15.54
3.0
2.4
u/l
55.8
56.0
0.02
172
985
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
242
1566
2.27
15.15
10.2
6.0
mmol/l
1.2
1.2
2.36
202
1325
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
83
336
2.83
14.59
8.0
6.9
kpa
5.0
5.1
1.00
78
324
(3013826) Glucose [Moles/volume] in Serum or Plasma
279
1934
2.30
14.54
6.8
4.2
mmol/l
6.7
6.5
0.78
271
1779
(3036481) Cortisol [Moles/volume] in Serum or Plasma
84
343
2.81
14.53
2.5
2.0
nmol/l
391.2
371.2
0.25
77
322
(3019060) Gas panel - Arterial blood
57
186
3.39
14.51
6.3
4.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
344
2625
2.66
14.24
11.5
7.1
u/l
77.5
76.5
0.16
332
2463
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
41
108
4.10
14.23
2.5
1.8
ug/l
11.3
3.8
0.35
33
99
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
120
596
2.41
13.83
5.3
3.7
ng/l
212.4
339.5
0.30
80
440
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
221
1433
2.14
13.10
8.6
5.2
mmol/l
1.2
1.2
1.87
206
1303
(3012095) Magnesium [Moles/volume] in Serum or Plasma
105
505
2.44
12.90
5.7
3.0
mmol/l
0.8
0.8
0.55
98
476
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
191
1177
2.14
12.87
4.3
2.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
56
5.08
12.55
1.9
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
62
236
2.91
12.12
7.4
7.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
39
5.90
12.07
1.8
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
67
267
2.79
12.03
3.1
2.6
g/l
9.6
10.0
0.44
60
249
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
20
8.28
11.96
3.2
2.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
142
800
2.17
11.87
2.6
1.7
mg/l
0.8
1.0
1.32
115
610
(3018418) pH of Serum or Plasma
162
967
2.09
11.60
5.5
3.5
ph
7.4
7.4
1.24
34
170
(3026008) Bacteria identified in Urine by Culture
165
995
2.08
11.47
4.0
2.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
24
49
5.13
11.35
1.9
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
190
1210
2.04
11.34
4.5
3.4
ng/l
26.9
34.4
0.55
123
761
(3031040) Bacteria [#/volume] in Urine by Automated count
299
2243
2.14
11.30
7.1
4.2
e6/l
397.7
168.5
—
9
37
(3014576) Chloride [Moles/volume] in Serum or Plasma
81
366
2.50
11.28
7.1
6.3
mmol/l
103.7
103.9
0.16
74
357
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
32
84
4.04
11.14
1.7
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
31
80
4.10
11.04
1.7
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
94
463
2.32
10.78
2.5
1.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
63
257
2.71
10.78
3.8
3.0
mmol/l
2.1
2.2
0.03
50
205
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
55
209
2.88
10.75
4.5
2.8
ng/l
200.5
184.8
0.11
50
184
(4010399)
61
247
2.72
10.58
1.4
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
124
691
2.12
10.47
3.2
2.4
e6/l
8.0
6.9
0.23
118
609
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
142
833
2.06
10.46
3.6
3.1
ng/l
1745.7
972.0
0.51
124
685
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
41
5.34
10.42
1.8
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
161
1013
1.95
9.56
4.0
2.8
e6/l
17.3
124.5
0.96
139
764
(3026782) Osmolality of Urine
116
654
2.07
9.37
3.1
2.5
mosm/kgh2o
496.4
551.8
2.01
108
552
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
56
233
2.62
9.18
2.2
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
46
4.75
9.16
1.7
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
141
870
1.93
8.73
12.5
6.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
302
2374
1.95
8.72
6.7
4.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
57
4.21
8.63
1.6
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
177
1183
1.85
8.51
4.8
2.9
u/l
41.3
30.0
0.52
166
1123
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
37
5.04
8.43
1.7
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
15
26
5.94
8.38
1.3
1.2
u/ml
0.4
0.1
—
8
12
(3037522) Nuclear Ab [Titer] in Serum
91
487
2.11
8.36
1.5
1.4
titre
773.3
486.0
0.79
21
120
(3020630) Protein [Mass/volume] in Serum or Plasma
54
232
2.52
8.28
2.1
2.7
g/l
65.5
67.2
1.08
47
218
(3018095) Leukocytes [#/volume] in Urine
180
1222
1.82
8.14
4.6
3.3
e6/l
54.0
70.2
0.33
144
828
(3015377) Calcium [Moles/volume] in Serum or Plasma
166
1104
1.83
8.00
3.3
3.2
mmol/l
2.3
2.4
2.21
146
987
(3017181) Myelocytes/100 leukocytes in Blood
60
276
2.37
7.93
4.8
4.4
%
0.7
1.0
0.47
23
92
(3000492) Spirometry study
69
339
2.24
7.83
1.3
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
396
3508
3.02
7.75
28.4
12.5
mg/l
22.8
21.7
0.29
369
2734
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
51
221
2.49
7.67
4.2
3.4
ng/l
82.3
74.1
0.25
46
201
(3044889) 12 lead EKG panel
295
2347
1.85
7.65
4.1
3.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
35
125
2.96
7.63
1.3
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
46
191
2.58
7.56
1.9
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
82
442
2.06
7.33
3.9
2.1
g/l
2.3
2.4
0.56
75
411
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
78
413
2.09
7.31
3.9
2.1
%
21.2
23.6
0.97
57
354
(44790049)
18
42
4.43
7.28
1.6
1.5
—
—
—
0
0
(44790047)
18
42
4.43
7.28
1.6
1.5
—
—
—
0
0
(44790048)
18
42
4.43
7.28
1.6
1.5
—
—
—
0
0
(44806118)
18
42
4.43
7.28
1.6
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
42
171
2.62
7.18
4.4
3.3
mmol/l
2.5
1.9
0.44
36
127
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
127
800
1.84
7.16
2.7
2.0
mg/l
3.1
3.0
0.09
108
683
(3013707) Erythrocyte sedimentation rate by Westergren method
315
2583
1.86
7.11
6.3
3.9
mm/h
15.6
10.5
5.72
301
2390
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
27
87
3.25
6.99
1.1
1.1
e6/l
11.0
2.6
0.43
22
66
(3023419) Bacteria identified in Sputum by Culture
16
35
4.71
6.99
4.6
2.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
53
246
2.32
6.85
4.8
4.2
%
0.4
0.5
0.29
17
58
(3023103) Potassium [Moles/volume] in Serum or Plasma
396
3548
2.82
6.80
29.0
13.7
mmol/l
3.9
3.9
0.22
391
3445
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
37
146
2.68
6.73
9.7
8.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
14
7.29
6.72
2.2
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
64
327
2.13
6.56
2.3
2.9
%
1.8
1.8
0.07
54
298
(3020891) Body temperature
31
113
2.88
6.53
4.7
4.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
21
60
3.63
6.52
4.2
2.5
mmol/l
3.1
2.9
0.13
11
41
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
118
746
1.81
6.49
2.0
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
138
915
1.75
6.45
3.9
2.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
176
1250
1.70
6.41
2.1
1.9
pmol/l
92.8
97.7
0.66
103
640
(3022948) Iron [Moles/volume] in Serum or Plasma
85
486
1.94
6.39
3.7
2.1
umol/l
11.6
13.8
2.75
78
450
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
15
6.80
6.34
2.3
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
15
6.80
6.34
2.2
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
42
182
2.45
6.32
4.6
3.2
ph
7.4
7.4
—
5
20
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
12
22
5.58
6.32
4.8
2.9
%
23.0
50.2
—
6
6
(3021440) Promyelocytes/100 leukocytes in Blood
53
257
2.21
6.18
5.2
4.5
%
0.1
0.1
0.57
18
81
(3024928) Oxygen saturation in Venous blood
21
63
3.46
6.08
3.6
2.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
216
1636
1.65
6.04
5.9
3.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
137
923
1.72
5.97
4.0
2.8
e6/l
0.2
0.4
2.18
113
676
(3004588) Protein electrophoresis panel - Serum or Plasma
43
194
2.35
5.93
2.3
2.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
48
229
2.24
5.82
2.9
2.4
ug/l
5.7
5.7
0.00
43
205
(3021901) Oxygen saturation in Capillary blood
18
50
3.72
5.82
2.2
2.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
14
32
4.49
5.81
2.1
1.8
%
89.4
90.3
0.25
14
32
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
192
1434
1.62
5.53
3.0
2.2
nmol/l
72.5
76.1
0.99
179
1292
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
25
4.91
5.52
1.2
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
15
38
4.06
5.48
1.8
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
219
1691
1.61
5.48
5.6
3.5
estimate
0.0
0.0
0.00
54
325
(3025159) Blasts/100 leukocytes in Blood
49
243
2.15
5.41
5.3
4.6
%
0.1
0.2
0.37
18
69
(3021960) Folate [Moles/volume] in Serum or Plasma
112
734
1.72
5.32
1.8
1.5
nmol/l
20.2
21.3
0.29
103
626
(3021601) Nitrite [Presence] in Urine by Test strip
217
1688
1.59
5.15
6.9
4.7
estimate
0.0
0.0
0.50
54
324
(40760892) CBC W Ordered Manual Differential panel - Blood
124
842
1.67
5.14
6.1
4.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
76
3.00
5.11
1.4
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
23
4.88
5.04
2.0
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
84
517
1.78
4.94
1.9
1.7
nmol/l
1200.4
1203.1
0.01
63
388
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
99
641
1.71
4.87
1.9
1.6
pmol/l
415.7
12249072.1
0.50
85
547
(3029937) Albumin [Presence] in Urine by Test strip
130
905
1.63
4.85
6.7
3.7
estimate
0.0
0.0
0.50
55
320
(3000475) Leukocytes [#/volume] in Synovial fluid
18
57
3.25
4.82
2.1
1.5
e6/l
17906.5
21356.3
0.08
13
39
(3019230) Fractional oxyhemoglobin in Venous blood
16
47
3.50
4.79
2.9
1.6
%
65.6
63.1
0.17
16
47
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
58
321
1.94
4.76
4.2
3.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
63
3.11
4.73
5.7
4.3
iu/ml
119.2
613.8
—
6
9
(3043409) Potassium [Moles/volume] in Arterial blood
25
97
2.68
4.73
6.2
3.8
mmol/l
4.0
3.9
0.23
20
87
(3009261) Glucose [Presence] in Urine by Test strip
217
1711
1.55
4.70
5.6
3.5
estimate
0.0
0.0
0.00
53
314
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
86
2.77
4.66
1.4
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
23
86
2.77
4.66
1.5
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
17
54
3.24
4.53
2.1
2.1
%
17.5
16.0
—
5
26
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
19
65
3.01
4.50
1.5
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
61
350
1.87
4.49
22.2
16.8
inr
1.5
1.3
—
10
47
(3030981) Hyaline casts [#/volume] in Urine by Automated count
36
171
2.21
4.43
2.9
2.4
e6/l
0.8
0.1
1.30
36
165
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
287
2427
1.57
4.41
4.0
2.9
u/l
53.6
43.0
1.13
274
2285
(3044640) Blood type and Crossmatch panel - Blood
148
1084
1.56
4.39
2.7
2.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
76
470
1.75
4.38
2.6
2.4
ug/g
207.3
119.7
0.86
63
367
(3001122) Ferritin [Mass/volume] in Serum or Plasma
205
1621
1.51
4.24
3.7
2.7
ug/l
149.8
99.6
1.87
191
1510
(3044290) Cell count panel - Cerebral spinal fluid
20
74
2.79
4.14
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
198
1565
1.50
4.04
15.9
8.7
e9/l
0.0
0.0
0.29
167
1277
(3019150) Specific gravity of Urine by Refractometry
108
749
1.59
4.00
6.4
3.6
kg/l
1.0
1.0
—
10
100
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
96
647
1.63
4.00
1.4
1.3
iu/ml
15.4
33.1
3.27
32
211
(3015171) Extractable nuclear Ab [Units/volume] in Serum
30
138
2.26
4.00
1.2
1.3
—
3.0
—
0
9
(40768443) Skin Pathology biopsy report
30
138
2.26
4.00
1.2
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
56
325
1.83
3.98
2.5
2.6
u/l
38.9
34.6
0.18
45
275
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
19
70
2.79
3.97
1.4
1.3
u/ml
200.5
228.0
0.25
13
41
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
400
3731
2.33
3.96
16.2
9.6
u/l
27.2
25.6
1.08
390
3613
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
315
2749
1.57
3.96
5.0
4.2
pmol/l
14.6
14.6
0.02
297
2518
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
11
7.39
3.87
2.0
3.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
11
7.39
3.87
2.0
3.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
60
2.91
3.84
2.5
3.7
e9/l
4.7
4.4
0.14
17
60
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
170
1313
1.49
3.83
6.0
3.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
132
972
1.52
3.72
3.6
2.9
mmol/l
8.1
7.8
0.20
114
815
(3022313) Gas panel - Capillary blood
29
137
2.20
3.64
4.4
3.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
17
62
2.81
3.63
2.5
4.1
%
59.7
56.2
0.49
17
62
(3000494) Fungus identified in Specimen by Culture
64
399
1.71
3.58
1.8
1.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
9
7.88
3.57
1.0
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
34
173
2.05
3.55
2.0
1.7
—
—
—
0
0
(4027681)
10
26
3.92
3.54
1.5
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
63
2.77
3.53
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
63
2.77
3.53
1.6
1.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
6
10.12
3.50
1.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
10
7.10
3.37
2.7
1.8
ug/l
56.4
66.8
—
7
10
(3013512) EKG study
121
893
1.50
3.33
3.9
3.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
109
2.27
3.32
2.8
2.3
g/l
3.1
3.1
0.01
16
88
(40761536) Microorganisms panel - Urine sediment
49
290
1.78
3.28
5.4
3.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
114
834
1.50
3.27
3.7
2.6
umol/l
338.3
6219.0
3.32
102
731
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
110
2.25
3.25
2.4
2.3
g/l
7.5
10.3
2.42
17
98
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
90
626
1.56
3.25
1.4
1.3
u/ml
7.4
11.3
0.43
37
243
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
38
3.22
3.23
4.9
3.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
12
38
3.22
3.23
1.1
1.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
15
5.41
3.20
1.3
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
11
6.45
3.19
1.7
2.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
11
6.45
3.19
7.4
7.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
39
3.14
3.11
1.2
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
119
2.17
3.11
2.7
2.3
g/l
7.5
7.4
0.08
16
92
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
119
2.17
3.11
2.7
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
119
2.17
3.11
2.7
2.3
g/l
3.2
3.8
1.74
16
86
(3023520) Reticulocytes [#/volume] in Blood
41
234
1.83
3.10
1.8
2.8
e9/l
73.5
73.5
0.00
28
176
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
87
2.36
3.05
1.2
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
117
872
1.47
3.04
4.1
3.1
mg/l
1864.2
434.2
0.79
77
555
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
50
305
1.73
3.03
2.3
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
105
767
1.49
3.01
5.6
3.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
23
108
2.19
2.96
1.2
1.2
u/ml
12.4
6.8
—
5
21
(3041096) Erythrocytes [Presence] in Urine by Automated
127
966
1.45
2.96
4.6
3.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
13
46
2.88
2.94
1.5
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
27
136
2.05
2.92
2.0
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
30
3.39
2.92
1.2
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
58
2.64
2.90
1.6
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
43
255
1.76
2.88
5.6
3.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
15
59
2.60
2.81
1.4
1.1
u/ml
0.3
1.7
—
10
21
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
19
84
2.32
2.81
1.3
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
18
4.51
2.80
4.0
2.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
18
4.51
2.80
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
392
3692
1.84
2.78
24.0
11.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
12
42
2.91
2.77
2.2
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
356
3275
1.55
2.76
26.9
13.3
%
39.1
40.0
1.12
251
2531
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
113
2.09
2.67
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
100
2.16
2.63
1.2
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
15
4.73
2.60
1.4
1.2
umol/l
29.5
30.1
—
7
15
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
20
4.06
2.58
2.9
2.9
u/ml
1691.0
773.5
—
8
20
(1616796) Gas panel - Central venous blood
15
62
2.47
2.57
3.7
1.9
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
45
280
1.68
2.56
1.9
2.2
g/l
0.2
0.2
0.76
40
262
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
50
2.65
2.55
4.2
1.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
74
520
1.51
2.54
3.4
2.6
e6/l
4.2
2.8
0.75
38
266
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
353
3257
1.51
2.53
5.8
4.9
mu/l
1.7
2.2
0.78
329
3010
(3020682) Albumin/Creatinine [Ratio] in Urine
119
918
1.41
2.52
4.3
3.8
mg/mmol
24.2
7.7
1.40
78
573
(3023511) Choriogonadotropin [Units/volume] in Urine
23
116
2.04
2.50
1.7
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
65
446
1.54
2.49
2.1
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
21
3.86
2.47
1.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
35
205
1.77
2.46
1.4
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
69
481
1.52
2.46
1.4
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
21
103
2.09
2.46
4.4
3.7
g/l
0.6
0.2
1.01
12
36
(3021879) Hepatitis B virus core Ab [Presence] in Serum
45
284
1.65
2.43
1.3
1.4
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
6
12
5.05
2.41
1.8
2.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
17
4.17
2.37
1.1
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
7
17
4.17
2.37
2.1
1.4
u/field
0.9
0.9
—
7
11
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
279
2487
1.36
2.30
4.7
3.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
120
1.97
2.30
2.5
2.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
41
2.73
2.29
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
42
265
1.65
2.28
3.9
2.6
ml/min/173m2
60.0
68.8
0.68
19
110
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
68
482
1.49
2.24
2.1
1.9
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
9
5.61
2.22
1.4
1.8
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
36
2.82
2.21
1.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
14
4.33
2.16
1.2
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
88
2.09
2.14
3.1
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
100
771
1.39
2.10
1.9
1.4
g/l
2.2
2.2
0.23
71
482
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
31
2.94
2.08
1.9
1.9
—
—
—
0
0
(4062490)
9
31
2.94
2.08
2.2
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
10
5.04
2.07
1.0
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
20
3.54
2.06
1.4
5.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
15
4.04
2.04
1.0
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
44
290
1.58
2.02
1.0
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
26
3.12
2.02
4.0
2.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
30
179
1.73
2.01
4.3
2.3
u/l
6420.8
3611.2
0.17
11
76
(3042631) Mycobacterium sp identified in Specimen
9
32
2.85
2.01
5.6
3.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
78
581
1.42
2.00
2.8
2.6
mmol/l
2.4
2.5
0.08
65
515
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
20
105
1.95
1.99
1.9
1.6
—
0.1
—
0
18
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
11
4.59
1.94
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
11
4.59
1.94
1.0
1.5
nmol/l
127.4
122.4
—
5
11
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
85
646
1.40
1.94
1.9
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
6
16
3.79
1.94
2.0
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
23
128
1.84
1.94
2.1
1.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
378
0.56
1.93
1.6
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
62
445
1.46
1.93
1.3
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
58
2.28
1.92
2.3
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
21
114
1.89
1.91
1.2
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
22
3.22
1.88
4.9
1.5
%
13.5
11.6
—
7
22
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
28
2.89
1.87
2.1
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
407
3931
1.93
1.86
38.6
18.4
e12/l
4.5
4.5
1.02
402
3827
(3010813) Leukocytes [#/volume] in Blood
407
3931
1.93
1.86
38.7
18.5
e9/l
7.5
6.7
3.62
402
3827
(42529406) Shigella sp [Presence] in Stool by Culture
21
115
1.87
1.86
1.2
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
101
796
1.35
1.85
2.1
1.9
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
12
4.20
1.83
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
73
2.09
1.83
1.9
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
35
2.60
1.81
1.1
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
29
2.79
1.80
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
107
856
1.33
1.77
1.2
1.3
u/ml
0.7
1.4
1.43
26
243
(1002224) Polysomnography panel
28
171
1.68
1.75
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
61
2.17
1.73
1.2
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
61
2.17
1.73
1.2
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
71
534
1.40
1.73
2.2
2.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
7
24
2.95
1.73
3.6
2.0
—
689.2
—
0
10
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
46
319
1.50
1.71
5.3
3.8
ug/l
17.6
43.7
0.47
36
260
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
19
3.19
1.66
1.2
1.1
miu/ml
1431.7
1788.6
—
6
19
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
36
238
1.56
1.66
2.1
1.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
56
2.18
1.62
1.6
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
13
63
2.10
1.61
1.2
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
32
2.53
1.60
1.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
15
3.36
1.52
1.0
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
15
3.36
1.52
1.6
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
15
3.36
1.52
1.6
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
350
3302
1.35
1.52
23.0
11.5
ml/min/173m2
84.5
85.5
0.34
299
2688
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
16
86
1.89
1.52
2.6
2.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
27
2.62
1.52
1.1
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
27
2.62
1.52
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
20
116
1.76
1.51
2.6
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
12
58
2.10
1.50
2.8
5.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
72
1.98
1.50
1.9
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
23
140
1.68
1.48
1.5
1.3
miu/ml
270.6
292.9
0.11
16
68
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
45
2.25
1.47
1.3
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
18
102
1.80
1.47
2.6
1.9
—
—
—
0
0
(3036489) Thrombin time
21
125
1.72
1.46
4.1
2.0
s
21.1
21.6
0.16
14
108
(3035947) Staphylolysin Ab [Units/volume] in Serum
6
22
2.75
1.44
1.3
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
71
552
1.34
1.42
3.5
2.5
e6/l
0.8
1.0
0.36
36
298
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
29
2.44
1.39
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
53
2.10
1.39
1.0
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
99
810
1.29
1.38
2.7
2.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
41
2.22
1.37
1.3
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
23
2.63
1.37
1.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
23
2.63
1.37
3.5
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
17
97
1.78
1.37
4.4
2.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
47
2.15
1.34
1.3
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
51
380
1.39
1.33
10.0
6.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
53
398
1.38
1.32
1.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
165
1442
1.24
1.32
2.3
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
76
1.87
1.31
2.5
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
43
2.12
1.31
1.1
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
53
400
1.37
1.29
1.6
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
55
2.03
1.28
1.3
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
44
2.07
1.27
1.2
1.3
—
—
—
0
0
(4035726)
40
290
1.42
1.23
1.7
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
31
214
1.48
1.22
1.3
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
19
2.65
1.22
1.2
2.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
19
2.65
1.22
2.0
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
331
3128
1.27
1.21
6.3
5.2
mmol/mol
40.6
39.1
1.47
311
2941
(44813793)
6
26
2.33
1.19
1.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
26
2.33
1.19
1.5
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
116
1350
0.81
1.18
2.8
2.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
50
2.02
1.17
1.2
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
87
1.75
1.16
1.5
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
351
3348
1.28
1.14
4.7
4.1
mmol/l
6.0
5.8
1.16
324
3092
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
58
1.92
1.13
1.2
1.5
—
—
—
0
0
(4306422)
11
58
1.92
1.13
1.4
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
30
2.36
1.13
1.3
1.2
titre
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
40
2.02
1.12
1.3
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
24
160
1.53
1.12
1.3
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
31
2.28
1.11
1.3
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
32
2.21
1.08
1.3
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
32
2.21
1.08
1.3
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
32
2.21
1.08
1.3
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
32
2.21
1.08
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
33
2.14
1.06
1.1
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
12
67
1.81
1.05
2.8
1.3
u/ml
78.6
108.5
—
5
16
(3000093) Morphology [Interpretation] in Blood Narrative
5
22
2.29
1.03
1.0
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
34
2.08
1.03
1.3
1.9
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
18
115
1.59
1.01
1.0
1.1
—
12.9
—
0
15
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
35
2.02
1.00
1.1
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
23
2.19
0.98
1.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
22
149
1.50
0.97
2.6
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
37
1.91
0.94
1.6
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
30
403
0.72
0.92
2.0
2.9
ug/l
0.6
0.7
0.20
14
247
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
28
2.16
0.92
4.5
1.4
ug/l
21.2
18.0
—
6
28
(3003327) Ova and parasites identified in Stool by Light microscopy
19
127
1.52
0.90
1.2
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
29
2.08
0.89
2.0
2.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
204
0.63
0.88
1.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
30
2.01
0.87
1.5
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
80
1.64
0.85
1.2
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
31
1.95
0.84
5.8
3.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
31
1.95
0.84
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
65
1.71
0.83
1.2
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
15
97
1.57
0.82
1.3
1.4
ug/g
359.1
322.9
—
9
54
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
55
450
1.26
0.80
1.8
1.7
%
1.4
1.4
0.11
43
404
(4281824)
6
33
1.83
0.79
1.8
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
48
1.68
0.79
1.3
1.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
7.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.6
—
1.1
—
0
27
(40768441) Liver Pathology biopsy report
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
344
3314
1.20
0.76
3.9
3.7
mmol/l
1.4
1.3
4.34
314
3070
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
67
1.66
0.76
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
24
2.10
0.74
2.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
24
2.10
0.74
1.0
3.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
33
421
0.77
0.74
1.3
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
31
238
1.33
0.73
3.5
2.3
e9/l
4.1
4.0
0.10
25
191
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
56
1.62
0.73
1.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
37
292
1.29
0.72
6.6
4.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
57
1.59
0.71
1.9
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
26
1.93
0.71
1.4
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
27
1.86
0.68
1.6
2.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
21
153
1.39
0.68
2.7
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
50
414
1.24
0.67
1.9
1.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
43
1.64
0.67
2.3
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
22
163
1.37
0.65
3.0
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
62
1.63
0.65
2.5
2.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
20
268
0.73
0.64
1.4
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
22
164
1.36
0.63
2.9
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
22
164
1.36
0.63
2.7
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
360
3499
1.19
0.62
4.8
4.6
mmol/l
2.9
2.8
0.18
330
3254
(1001926) Buprenorphine [Presence] in Urine by Screen method
18
130
1.40
0.62
2.0
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
82
723
1.17
0.58
1.5
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
35
1.72
0.58
1.5
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
86
0.58
0.57
7.4
4.7
—
—
—
0
0
(4034850)
8
125
0.63
0.55
10.6
8.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
38
1.59
0.54
1.0
1.1
—
—
—
0
0
(4268621)
6
39
1.55
0.53
2.7
2.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
100
1.41
0.52
1.9
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
127
1.35
0.50
2.1
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
27
218
1.25
0.48
4.2
2.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
21
164
1.30
0.47
3.0
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
48
1.47
0.47
3.9
1.3
—
—
—
0
0
(4094501)
5
85
0.58
0.45
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
50
1.41
0.45
1.1
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
8
57
1.41
0.42
1.3
1.3
ug/l
4.0
3.3
—
8
49
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3016750) Collection duration of Urine
0
16
0.00
0.41
0.0
2.2
—
492.0
—
0
8
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
18
0.00
0.40
0.0
2.6
—
583.2
—
0
9
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
5
35
1.43
0.39
1.6
2.0
—
16.2
—
0
10
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
34
397
0.84
0.39
4.3
4.0
%
31.5
31.8
0.05
24
269
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
36
1.39
0.38
1.0
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
67
1.35
0.38
1.3
1.5
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
37
1.36
0.37
2.0
3.1
nmol/l
10.7
3.4
—
5
37
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
70
1.29
0.37
1.1
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
99
1.32
0.36
1.7
2.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
42
1.43
0.35
1.7
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
43
1.40
0.35
1.7
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
43
1.40
0.35
1.7
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
44
1.37
0.34
1.7
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
350
3432
1.11
0.34
4.3
4.0
mmol/l
1.5
1.5
1.47
322
3197
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
53
1.33
0.31
1.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
34
298
1.15
0.29
1.4
1.2
iu/ml
83.4
164.2
1.80
13
127
(3014051) Protein [Presence] in Urine by Test strip
10
76
1.32
0.28
3.8
2.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
74
684
1.10
0.28
3.9
4.5
ug/l
1.4
2.5
1.28
65
609
(3025130) Human papilloma virus identified in Specimen
8
65
1.24
0.27
1.6
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
161
1.19
0.24
2.4
2.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
91
0.77
0.22
2.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
41
1.22
0.22
2.0
2.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
1.8
1.2
nmol/l
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
11
0.00
0.21
0.0
11.3
—
—
—
0
0
(4133840)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
43
1.16
0.21
1.6
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
112
0.80
0.20
1.8
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
49
1.23
0.20
2.5
2.0
u/ml
3.6
6.4
—
6
43
(3001019) Free T4 and TSH panel - Serum or Plasma
21
239
0.87
0.20
1.4
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
349
3446
1.07
0.19
4.5
4.1
mmol/l
4.8
4.8
0.14
324
3224
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
6
53
1.13
0.18
2.7
1.7
pmol/l
145.5
215.7
—
6
48
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
19
166
1.15
0.18
1.5
1.9
mg/l
4.0
2.8
0.51
14
116
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
140
1.15
0.15
1.6
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
58
548
1.07
0.15
3.6
4.1
%
23.1
20.8
0.16
11
246
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
84
1.20
0.14
1.2
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
122
1.15
0.14
1.1
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
25
229
1.10
0.12
1.1
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
48
456
1.06
0.11
2.0
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
134
0.89
0.09
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
134
0.89
0.09
1.4
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
61
0.82
0.08
1.4
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
133
0.90
0.07
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
133
0.90
0.07
1.4
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
6
70
0.86
0.07
2.0
2.5
umol/l
4.8
4.8
—
6
54
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
74
1.08
0.07
1.4
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
111
0.90
0.06
1.4
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
89
907
0.98
0.05
1.8
1.6
mmol/l
1.7
1.4
2.00
76
779
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
108
0.92
0.03
1.4
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
138
0.94
0.02
2.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
107
0.93
0.02
1.4
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
142
0.99
0.00
1.4
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
16
162
0.99
0.00
4.4
3.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
102
1018
1.00
0.00
1.6
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
24
241
1.00
0.00
1.4
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
16
157
1.02
0.00
1.4
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
19
186
1.02
0.00
1.2
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
4.4
—
0
5
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
9
91
0.99
0.00
8.6
2.1
mg/l
1.7
1.4
—
9
84
(3003129) Base excess in Capillary blood by calculation
0
7
0.00
0.00
0.0
1.1
—
1.7
—
0
7
(4015189)
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint ANAPH_SHOCK_ADVER_EFFECT_CORRE_DRUG_MEDICAM_PROPE_ADMINISTE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ANAPH_SHOCK_ADVER_EFFECT_CORRE_DRUG_MEDICAM_PROPE_ADMINISTE | 2.664 [2.09, 3.4] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.195 |
During the follow-up period (1.1.1998 — 31.12.2019), 249 out of 1378 females with ANAPH_SHOCK_ADVER_EFFECT_CORRE_DRUG_MEDICAM_PROPE_ADMINISTE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ANAPH_SHOCK_ADVER_EFFECT_CORRE_DRUG_MEDICAM_PROPE_ADMINISTE | 2.263 [1.67, 3.07] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.023 |
During the follow-up period (1.1.1998 — 31.12.2019), 140 out of 723 males with ANAPH_SHOCK_ADVER_EFFECT_CORRE_DRUG_MEDICAM_PROPE_ADMINISTE died.
Mortality risk
Mortality risk for people of age
years, who have ANAPH_SHOCK_ADVER_EFFECT_CORRE_DRUG_MEDICAM_PROPE_ADMINISTE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.262% | 0.476% |
| 5 | 1.442% | 2.752% |
| 10 | 3.806% | 6.509% |
| 15 | 7.505% | 12.835% |
| 20 | 12.907% | 22.173% |
Relationships between endpoints
↥Index endpoint: ANAPH_SHOCK_ADVER_EFFECT_CORRE_DRUG_MEDICAM_PROPE_ADMINISTE – Anaphylactic shock due to adverse effect of correct drug or medication properly administered
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data